SD

Sutapa Das

Active Director Director DIN 08870300
DIN 08870300 First appointment Sep 2020 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2020
Shareholding value •••• Premium profile

About Sutapa Das

Data last updated:

Sutapa Das is a Director at Austere Remedies Private Limited (since 2020). The company operates in Trading. Austere Remedies Private Limited reported revenue of ₹75.1 Lakh (FY 2025).

DIN 08870300
Primary Designation Director
Industry Trading
First Appointment 10 Sep 2020
Oldest Company Age 8 yrs
Largest company Austere Remedies Private Limited · ₹75.1 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Austere Remedies Private Limited U51909WB2017PTC223562
Director10 Sep 20202017₹75.1 Lakh (FY 2025)Active

Board colleagues of Sutapa Das

NameDINCompanyDesignation
Sutarna Banerjee08873404Austere Remedies Private LimitedDirector

Directorship timeline

Open interactive timeline →
Austere Remedies Private Limited
Premium access

Shareholding and investment profile for Sutapa Das

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sutapa Das

Sutapa Das currently holds 1 directorship: Austere Remedies Private Limited (Director, since 10 Sep 2020, revenue ₹75.1 Lakh (FY 2025)).

Sutapa Das was first appointed on 10 Sep 2020 as Director at Austere Remedies Private Limited.

The current boards of Sutapa Das's companies include Sutarna Banerjee (Austere Remedies Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available